WT1 Enhances Proliferation and Impedes Apoptosis in KRAS Mutant NSCLC via Targeting cMyc
Background: A novel link between oncogenic KRAS signalling and WT1 was recently identified. We sought to investigate the role of WT1 and KRAS in proliferation and apoptosis. Methods: KRAS mutations and WT1 (cMyc) expression were detected using Sanger sequencing and real-time PCR in 77 patients with...
Main Authors: | Chen Wu, Sihan Wang, Caihua Xu, Andreas Tyler, Xingru Li, Charlotta Andersson, Yusuke Oji, Haruo Sugiyama, Yijiang Chen, Aihong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2015-01-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/369726 |
Similar Items
-
cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis
by: Hany I. Sakr, et al.
Published: (2017-10-01) -
WT1 påverkar proliferationen för cancercellinjer troligen via reglering av c-Myc
by: Eriksson, Jonathan
Published: (2011) -
PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis
by: Yi Qin, et al.
Published: (2019-03-01) -
Gene Mutation Analysis in EGFR Wild Type NSCLC Responsive to Erlotinib: Are There Features to Guide Patient Selection?
by: Paola Ulivi, et al.
Published: (2014-12-01) -
TRIM66 Overexpression Promotes Glioma Progression and Regulates Glucose Uptake Through cMyc/GLUT3 Signaling
by: Song Y, et al.
Published: (2021-06-01)